Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2014

01.07.2014 | Clinical trial

Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?

verfasst von: Eva Maria Fallenberg, Clarisse Dromain, Felix Diekmann, Diane M. Renz, Heba Amer, Barbara Ingold-Heppner, Avidan U. Neumann, Klaus J. Winzer, Ulrich Bick, Bernd Hamm, Florian Engelken

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to compare contrast-enhanced spectral mammography (CESM) with mammography (MG) and combined CESM + MG in terms of detection and size estimation of histologically proven breast cancers in order to assess the potential to reduce radiation exposure. A total of 118 patients underwent MG and CESM and had final histological results. CESM was performed as a bilateral examination starting 2 min after injection of iodinated contrast medium. Three independent blinded radiologists read the CESM, MG, and CESM + MG images with an interval of at least 4 weeks to avoid case memorization. Sensitivity and size measurement correlation and differences were calculated, average glandular dose (AGD) levels were compared, and breast densities were reported. Fisher’s exact and Wilcoxon tests were performed. A total of 107 imaging pairs were available for analysis. Densities were ACR1: 2, ACR2: 45, ACR3: 42, and ACR4: 18. Mean AGD was 1.89 mGy for CESM alone, 1.78 mGy for MG, and 3.67 mGy for the combination. In very dense breasts, AGD of CESM was significantly lower than MG. Sensitivity across readers was 77.9 % for MG alone, 94.7 % for CESM, and 95 % for CESM + MG. Average tumor size measurement error compared to postsurgical pathology was −0.6 mm for MG, +0.6 mm for CESM, and +4.5 mm for CESM + MG (p < 0.001 for CESM + MG vs. both modalities). CESM alone has the same sensitivity and better size assessment as CESM + MG and was significantly better than MG with only 6.2 % increase in AGD. The combination of CESM + MG led to systematic size overestimation. When a CESM examination is planned, additional MG can be avoided, with the possibility of saving up to 61 % of radiation dose, especially in patients with dense breasts.
Literatur
1.
Zurück zum Zitat Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225(1):165–175PubMedCrossRef Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225(1):165–175PubMedCrossRef
2.
Zurück zum Zitat Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D’Orsi C, Jong R, Rebner M, Digital Mammographic Imaging Screening Trial Investigators G (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353(17):1773–1783. doi:10.1056/NEJMoa052911 PubMedCrossRef Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D’Orsi C, Jong R, Rebner M, Digital Mammographic Imaging Screening Trial Investigators G (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353(17):1773–1783. doi:10.​1056/​NEJMoa052911 PubMedCrossRef
3.
Zurück zum Zitat Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J, Fohlin H, Smith RA, Duffy SW (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260(3):658–663. doi:10.1148/radiol.11110469 PubMedCrossRef Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J, Fohlin H, Smith RA, Duffy SW (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260(3):658–663. doi:10.​1148/​radiol.​11110469 PubMedCrossRef
4.
Zurück zum Zitat Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, Greenlee RT, Kruger RL, Hornbrook MC, Roblin D, Solberg LI, Vanneman N, Weinmann S, Williams AE (2012) Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996–2010. J Am Med Assoc 307(22):2400–2409. doi:10.1001/jama.2012.5960 CrossRef Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, Greenlee RT, Kruger RL, Hornbrook MC, Roblin D, Solberg LI, Vanneman N, Weinmann S, Williams AE (2012) Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996–2010. J Am Med Assoc 307(22):2400–2409. doi:10.​1001/​jama.​2012.​5960 CrossRef
6.
Zurück zum Zitat Institute of Medicine of the National Academes (2011) Breast cancer and the environment: a life course approach. Rep Br December:1–4 Institute of Medicine of the National Academes (2011) Breast cancer and the environment: a life course approach. Rep Br December:1–4
8.
Zurück zum Zitat Agency IAE (2002) International action plan for the radiological protection of patients. Gov/2002/36-GC(46)/12:1–9 Agency IAE (2002) International action plan for the radiological protection of patients. Gov/2002/36-GC(46)/12:1–9
9.
Zurück zum Zitat Eastman TR (2013) ALARA and digital imaging systems. Radiol Technol 84(3):297–298PubMed Eastman TR (2013) ALARA and digital imaging systems. Radiol Technol 84(3):297–298PubMed
11.
Zurück zum Zitat Potter-Lang S, Dunkelmeyer M, Uffmann M (2012) Dose reduction and adequate image quality in digital radiography: a contradiction? Der Radiol 52(10):898–904. doi:10.1007/s00117-012-2337-9 Potter-Lang S, Dunkelmeyer M, Uffmann M (2012) Dose reduction and adequate image quality in digital radiography: a contradiction? Der Radiol 52(10):898–904. doi:10.​1007/​s00117-012-2337-9
12.
Zurück zum Zitat Shaw P, Crouail P (2013) ALARA in existing exposure situations: 14th European ALARA network workshop, 4–6 September 2012, Dublin. J Radiol Prot Off J Soc Radiol Prot 33(2):487–490. doi:10.1088/0952-4746/33/2/M02 Shaw P, Crouail P (2013) ALARA in existing exposure situations: 14th European ALARA network workshop, 4–6 September 2012, Dublin. J Radiol Prot Off J Soc Radiol Prot 33(2):487–490. doi:10.​1088/​0952-4746/​33/​2/​M02
13.
Zurück zum Zitat Dromain C, Thibault F, Diekmann F, Fallenberg EM, Jong RA, Koomen M, Hendrick RE, Tardivon A, Toledano A (2012) Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study. Breast Cancer Res 14(3):R94. doi:10.1186/bcr3210 PubMedCentralPubMedCrossRef Dromain C, Thibault F, Diekmann F, Fallenberg EM, Jong RA, Koomen M, Hendrick RE, Tardivon A, Toledano A (2012) Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study. Breast Cancer Res 14(3):R94. doi:10.​1186/​bcr3210 PubMedCentralPubMedCrossRef
14.
15.
Zurück zum Zitat Fallenberg EM, Dromain C, Diekmann F, Engelken F, Krohn M, Singh JM, Ingold-Heppner B, Winzer KJ, Bick U, Renz DM (2014) Contrast-enhanced spectral mammography versus MRI: initial results in the detection of breast cancer and assessment of tumour size. Eur Radiol 24(1):256–264. doi:10.1007/s00330-013-3007-7 PubMedCrossRef Fallenberg EM, Dromain C, Diekmann F, Engelken F, Krohn M, Singh JM, Ingold-Heppner B, Winzer KJ, Bick U, Renz DM (2014) Contrast-enhanced spectral mammography versus MRI: initial results in the detection of breast cancer and assessment of tumour size. Eur Radiol 24(1):256–264. doi:10.​1007/​s00330-013-3007-7 PubMedCrossRef
16.
Zurück zum Zitat Puong S, Bouchevreau X, Patoureaux F, Iordache R, Muller S (2007) Dual-energy contrast enhanced digital mammography using a new approach for breast tissue cancelling. Proc SPIE Med Imaging 6510:65102H. doi:10.1117/12.710133 CrossRef Puong S, Bouchevreau X, Patoureaux F, Iordache R, Muller S (2007) Dual-energy contrast enhanced digital mammography using a new approach for breast tissue cancelling. Proc SPIE Med Imaging 6510:65102H. doi:10.​1117/​12.​710133 CrossRef
17.
Zurück zum Zitat Braun M, Polcher M, Schrading S, Zivanovic O, Kowalski T, Flucke U, Leutner C, Park-Simon TW, Rudlowski C, Kuhn W, Kuhl CK (2008) Influence of preoperative MRI on the surgical management of patients with operable breast cancer. Breast Cancer Res Treat 111(1):179–187. doi:10.1007/s10549-007-9767-5 PubMedCrossRef Braun M, Polcher M, Schrading S, Zivanovic O, Kowalski T, Flucke U, Leutner C, Park-Simon TW, Rudlowski C, Kuhn W, Kuhl CK (2008) Influence of preoperative MRI on the surgical management of patients with operable breast cancer. Breast Cancer Res Treat 111(1):179–187. doi:10.​1007/​s10549-007-9767-5 PubMedCrossRef
19.
Zurück zum Zitat Diekmann F, Diekmann S, Jeunehomme F, Muller S, Hamm B, Bick U (2005) Digital mammography using iodine-based contrast media: initial clinical experience with dynamic contrast medium enhancement. Invest Radiol 40(7):397–404PubMedCrossRef Diekmann F, Diekmann S, Jeunehomme F, Muller S, Hamm B, Bick U (2005) Digital mammography using iodine-based contrast media: initial clinical experience with dynamic contrast medium enhancement. Invest Radiol 40(7):397–404PubMedCrossRef
20.
Zurück zum Zitat Dromain C, Balleyguier C, Muller S, Mathieu MC, Rochard F, Opolon P, Sigal R (2006) Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography. AJR Am J Roentgenol 187(5):W528–W537. doi:10.2214/AJR.05.1944 PubMedCrossRef Dromain C, Balleyguier C, Muller S, Mathieu MC, Rochard F, Opolon P, Sigal R (2006) Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography. AJR Am J Roentgenol 187(5):W528–W537. doi:10.​2214/​AJR.​05.​1944 PubMedCrossRef
23.
Zurück zum Zitat Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, Ioffe OB (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233(3):830–849. doi:10.1148/radiol.2333031484 PubMedCrossRef Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, Ioffe OB (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233(3):830–849. doi:10.​1148/​radiol.​2333031484 PubMedCrossRef
24.
Zurück zum Zitat Bosch AM, Kessels AG, Beets GL, Rupa JD, Koster D, van Engelshoven JM, von Meyenfeldt MF (2003) Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours. Eur J Radiol 48(3):285–292PubMedCrossRef Bosch AM, Kessels AG, Beets GL, Rupa JD, Koster D, van Engelshoven JM, von Meyenfeldt MF (2003) Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours. Eur J Radiol 48(3):285–292PubMedCrossRef
25.
Zurück zum Zitat Fasching PA, Heusinger K, Loehberg CR, Wenkel E, Lux MP, Schrauder M, Koscheck T, Bautz W, Schulz-Wendtland R, Beckmann MW, Bani MR (2006) Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. Eur J Radiol 60(3):398–404. doi:10.1016/j.ejrad.2006.08.002 PubMedCrossRef Fasching PA, Heusinger K, Loehberg CR, Wenkel E, Lux MP, Schrauder M, Koscheck T, Bautz W, Schulz-Wendtland R, Beckmann MW, Bani MR (2006) Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. Eur J Radiol 60(3):398–404. doi:10.​1016/​j.​ejrad.​2006.​08.​002 PubMedCrossRef
26.
Zurück zum Zitat Esserman L, Cowley H, Eberle C, Kirkpatrick A, Chang S, Berbaum K, Gale A (2002) Improving the accuracy of mammography: volume and outcome relationships. J Natl Cancer Inst 94(5):369–375PubMedCrossRef Esserman L, Cowley H, Eberle C, Kirkpatrick A, Chang S, Berbaum K, Gale A (2002) Improving the accuracy of mammography: volume and outcome relationships. J Natl Cancer Inst 94(5):369–375PubMedCrossRef
27.
Zurück zum Zitat Lobbes MB, Lalji U, Houwers J, Nijssen EC, Nelemans PJ, van Roozendaal L, Smidt ML, Heuts E, Wildberger JE (2014) Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme. Eur Radiol. doi:10.1007/s00330-014-3154-5 PubMed Lobbes MB, Lalji U, Houwers J, Nijssen EC, Nelemans PJ, van Roozendaal L, Smidt ML, Heuts E, Wildberger JE (2014) Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme. Eur Radiol. doi:10.​1007/​s00330-014-3154-5 PubMed
28.
Zurück zum Zitat Dance DR, Skinner CL, Young KC, Beckett JR, Kotre CJ (2000) Additional factors for the estimation of mean glandular breast dose using the UK mammography dosimetry protocol. Phys Med Biol 45(11):3225–3240PubMedCrossRef Dance DR, Skinner CL, Young KC, Beckett JR, Kotre CJ (2000) Additional factors for the estimation of mean glandular breast dose using the UK mammography dosimetry protocol. Phys Med Biol 45(11):3225–3240PubMedCrossRef
Metadaten
Titel
Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?
verfasst von
Eva Maria Fallenberg
Clarisse Dromain
Felix Diekmann
Diane M. Renz
Heba Amer
Barbara Ingold-Heppner
Avidan U. Neumann
Klaus J. Winzer
Ulrich Bick
Bernd Hamm
Florian Engelken
Publikationsdatum
01.07.2014
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2014
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-3023-6

Weitere Artikel der Ausgabe 2/2014

Breast Cancer Research and Treatment 2/2014 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.